Waning immunity after single-dose yellow fever vaccination: Who needs a second shot?

Leo G Visser¹, Olivia Veit^{2

3

4}, Lin H Chen^{5

6}

Affiliations

¹ Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
² Department of Medicine, Swiss Tropical and Public Health Institute, Basel, Switzerland.
³ University of Basel, Basel, Switzerland.
⁴ Institute of Epidemiology, Biostatistics and Prevention, University of Zürich, Switzerland.
⁵ Division of Infectious Diseases and Travel Medicine, Mount Auburn Hospital, Cambridge, MA, USA.
⁶ Faculty of Medicine, Harvard Medical School, Boston, MA, USA.

Comment

Leo G Visser et al. J Travel Med. 2019.

. 2019 Oct 14;26(7):tay134.

doi: 10.1093/jtm/tay134.

Leo G Visser¹, Olivia Veit^{2

3

4}, Lin H Chen^{5

6}

¹ Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
² Department of Medicine, Swiss Tropical and Public Health Institute, Basel, Switzerland.
³ University of Basel, Basel, Switzerland.
⁴ Institute of Epidemiology, Biostatistics and Prevention, University of Zürich, Switzerland.
⁵ Division of Infectious Diseases and Travel Medicine, Mount Auburn Hospital, Cambridge, MA, USA.
⁶ Faculty of Medicine, Harvard Medical School, Boston, MA, USA.

No abstract available

Comment on

Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among US travellers.
Lindsey NP, Horiuchi KA, Fulton C, Panella AJ, Kosoy OI, Velez JO, Krow-Lucal ER, Fischer M, Staples JE. Lindsey NP, et al. J Travel Med. 2018 Jan 1;25(1):10.1093/jtm/tay108. doi: 10.1093/jtm/tay108. J Travel Med. 2018. PMID: 30346562 Free PMC article.